| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,430 | $30 | $193.2K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 5,000 | $30 | $170K |
| J3262 | Injection, tocilizumab, 1 mg | 23,600 | $10 | $118K |
| J0897 | Injection, denosumab, 1 mg | 4,020 | $20 | $68.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 3,900 | $10 | $42.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 240 | $110 | $25.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 260 | $90 | $23.2K |
| J1201 | Injection, cetirizine hydrochloride, 0.5 mg | 720 | $10 | $7.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 120 | $50 | $6.1K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 230 | $20 | $5.3K |